Humoral Rejection

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2017-09-21
Clinical Trial Update: Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation [Phase 2]
Phase 2 trial of eculizumab for antibody-mediated rejection after kidney transplant was terminated; results posted in 2017.